当前位置:首页 - 行情中心 - 富士达(835640) - 财务分析 - 利润表

富士达

(835640)

  

流通市值:53.55亿  总市值:55.66亿
流通股本:1.81亿   总股本:1.88亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入408,345,846.87189,788,487.97762,797,542.26558,665,461.56
  营业收入408,345,846.87189,788,487.97762,797,542.26558,665,461.56
二、营业总成本350,807,064.71162,114,031.05694,589,275.95502,374,379.99
  营业成本261,824,651.17120,641,494.3513,397,197.07374,676,576.1
  税金及附加5,011,603.882,450,522.419,469,137.296,991,357.65
  销售费用10,110,581.225,203,982.4719,852,561.7912,955,743.09
  管理费用36,403,709.4318,050,090.0163,986,495.2143,163,238.94
  研发费用36,756,684.1515,485,699.0886,390,653.763,439,040.13
  财务费用699,834.86282,242.781,493,230.891,148,424.08
  其中:利息费用878,836.63414,392.471,926,875.991,490,997.89
  其中:利息收入299,357.85220,776.98629,962.45534,325.89
三、其他经营收益
  加:投资收益455,464.173,249.51589,853338,439.37
  资产处置收益---142,808.59-50,076.95
  资产减值损失(新)-1,534,081.66-232,518.02-3,621,100.52-956,543.29
  信用减值损失(新)-17,698,094.33-16,448,905.68-23,394,320-21,483,325.69
  其他收益4,973,813.142,936,470.2413,349,049.148,857,800.6
四、营业利润43,735,883.4813,932,752.9754,988,939.3442,997,375.61
  加:营业外收入534,243.6810,135.54262,891.68143,255.23
  减:营业外支出16,258.6615,860.72326,003.65204,419.27
五、利润总额44,253,868.513,927,027.7954,925,827.3742,936,211.57
  减:所得税费用1,446,112.17-375,770.47-4,087,525.67-1,125,748.97
六、净利润42,807,756.3314,302,798.2659,013,353.0444,061,960.54
(一)按经营持续性分类
  持续经营净利润42,807,756.3314,302,798.2659,013,353.0444,061,960.54
(二)按所有权归属分类
  归属于母公司股东的净利润37,177,486.6712,370,621.1851,126,712.3935,992,194.25
  少数股东损益5,630,269.661,932,177.087,886,640.658,069,766.29
  扣除非经常损益后的净利润36,554,056.9312,064,826.1749,131,783.4631,131,278.81
七、每股收益
  (一)基本每股收益0.20.070.270.19
  (二)稀释每股收益0.20.070.270.19
八、其他综合收益-0--11,863.62
  归属于母公司股东的其他综合收益-0--11,863.62
九、综合收益总额42,807,756.3314,302,798.2659,013,353.0444,050,096.92
  归属于母公司股东的综合收益总额37,177,486.6712,370,621.1851,126,712.3935,980,330.63
  归属于少数股东的综合收益总额5,630,269.661,932,177.087,886,640.658,069,766.29
公告日期2025-08-292025-04-282025-03-282024-10-29
审计意见(境内)标准无保留意见
TOP↑